News

Surgical Manual from Roswell Park Created to Advance Bladder Cancer Surgery Worldwide

Roswell Park Comprehensive Cancer Center announces the release of a new operative surgical manual authored by Khurshid Guru, MD.

Video

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

A new era in transplantation is here. Roswell Park reports a remarkable 92.6% one-year survival rate following allogeneic transplant—well above the national average—thanks to evidence-based innovations transforming patient care.

Symposium

Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th Annual ASH Meeting

Featuring speakers from nationally recognized institutes from across the country and led by experts from Roswell Park Comprehensive Cancer Center, the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting.

News

Roswell Park Introduces Gyn-Onc Connect Line for Consultation

To better service community practitioners, Roswell Park Comprehensive Cancer Center is proud to introduce Gyn-Onc Connect, a dedicated phone number to access Roswell Park’s gynecologic oncology team.

Video

Case Study: BRCA Mutation Led To Early Detection of Pre-Ovarian Cancer Condition

A 59-year-old woman was referred to Nicole Gaulin, MD, a gynecologic oncologist at Roswell Park Comprehensive Cancer Center, after learning she had a BRCA2 mutation linked with both breast cancer in a cousin and colon cancer in her father.

Video

Roswell Park Launches Exclusive Phase 1 Clinical Trial of ‘Armored’ CAR T-Cell Therapy for Ovarian Cancer

Roswell Park Comprehensive Cancer Center is currently recruiting for a phase 1 clinical trial of the new therapy (NCT07489287), called GB-5267, which was co-developed by Roswell Park and the therapeutics company Generate:Biomedicines.